Nanotoxicology and in vitro studies: The need of the hour

Toxicology and Applied Pharmacology

Volumn 258, Issue 2, 2012, Pages 151-165

  Arora, Sumit ^a   Rajwade, Jyutika M ^a   Paknikar, Kishore M ^a  

^a AGHARKAR RESEARCH INSTITUTE   (India)

Author keywords

Bio distribution of nanoparticles; Genotoxicity of nanoparticles; In vitro cytotoxicity; Molecular determinants of nanotoxicology; Nanotoxicology

Indexed keywords

BERYLLIUM; CARBON NANOTUBE; CATALASE; COPPER; DENDRIMER; FREE RADICAL; FULLERENE; GLUTATHIONE PEROXIDASE; GOLD NANOPARTICLE; HYDROGEN PEROXIDE; IRON OXIDE; IRON OXIDE NANOPARTICLE; MACROGOL; MAGNESIUM OXIDE; MULTI WALLED NANOTUBE; NANOCOPPER; NANOMATERIAL; NANOPARTICLE; NANOSILVER; POLYMER; POLYSTYRENE; QUANTUM DOT; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; SILVER; SINGLE WALLED NANOTUBE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIBODY RESPONSE; CHEMICAL COMPOSITION; CHROMOSOME ABERRATION; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DNA DAMAGE; ECOTOXICOLOGY; EXPOSURE; GASTROINTESTINAL TOXICITY; GENOTOXICITY; GOVERNMENT REGULATION; HEMOLYSIS; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; IMMUNOGENICITY; IMMUNOTOXICITY; IN VITRO STUDY; INFLAMMATION; LUNG TOXICITY; MICELLE; MOLECULAR DYNAMICS; MUTAGENESIS; NANOTECHNOLOGY; NANOTOXICOLOGY; NEUROTOXICITY; NONHUMAN; OPSONIZATION; OXIDATIVE STRESS; PARTICLE SIZE; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; RESPIRATORY SYSTEM; REVIEW; RISK ASSESSMENT; SKIN TOXICITY; SURFACE PROPERTY; TOXICITY TESTING; TOXICOKINETICS;

ANIMALS; HUMANS; MUTAGENICITY TESTS; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; RESEARCH DESIGN; TISSUE DISTRIBUTION; TOXICITY TESTS;

EID: 84855785145     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.11.010     Document Type: Review

References (185)

1. Adams L.K., Lyon D.Y., McIntosh A., Alvarez P.J.J. Comparative eco-toxicity of nano-scale TiO2, SiO2 and ZnO water suspensions. Water Res. 2006, 40:3527-3532.
2. Alfaro-Moreno E., Nawrot T.S., Nemmar A., Nemery B. Particulate matter in the environment: pulmonary and cardiovascular effects. Curr. Opin. Pulm. Med. 2007, 13:98-106.
3. Arora S., Jain J., Rajwade J.M., Paknikar K.M. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol. Lett. 2008, 179:93-100.
4. Arora S., Jain J., Rajwade J.M., Paknikar K.M. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol. Appl. Pharmacol. 2009, 236:310-318.
5. 2, SiC nanoparticles and multi-walled carbon nanotubes exposure in several mammalian cell types: an in vitro study. J. Nanopart. Res. 2010, 12:61-73.
6. Becker H., Herzberg F., Schulte A., Kolossa-Gehring M. The carcinogenic potential of nanomaterials, their release from products and options for regulating them. Int. J. Hyg. Environ. Health 2011, 214:231-238.
7. BeruBe K., Balharry D., Sexton K., Koshy L., Jones T. Combustion derived nanoparticles: mechanisms of pulmonary toxicity. Clin. Exp. Pharmacol. Physiol. 2007, 34:1044-1050.
8. Bottini M., Bruckner S., Nika K., Bottini N., Bellucci S., Magrini A., Bergamaschi A., Mustelin T. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol. Lett. 2006, 160:121-126.
9. Chen J., Han C.M., Lin X.W., Tang Z.J., Su S.J. Effect of silver nanoparticle dressing on second degree burn wound. Zhonghua Wai Ke Za Zhi 2006, 44:50-52.
10. Chen Z., Meng H., Zing G., Chen C., Zhao Y., Jia G., Wang T., Yuan H., Ye C., Zhao F., Chai Z., Zhu C., Fang X., Ma B., Wan L. Acute toxicological effects of copper nanoparticles in vivo. Toxicol. Lett. 2006, 163:109-120.
11. Chithrani B.D., Ghazani A.A., Chan W.C.W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006, 4:662-668.
12. Christie M.S., Wahi R., Preetha A.K., Liu Y., Jennifer L.W., Kevin D.A., David B.W., Vicki L.C. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol. Sci. 2006, 92:174-185.
13. Chung I.-S., Lee M.-Y., Shin D.-H., Jung H.-R. Three systemic argyria cases after ingestion of colloidal silver solution. Int. J. Dermatol. 2010, 49:1175-1177.
14. Curtis J., Greenberg M., Kester J., Phillips S., Krieger G. Nanotechnology and nanotoxicology: a primer for clinicians. Toxicol. Sci. 2006, 25:245-260.
15. de Lima R., Feitosa L., Pereira A.E.S., de Moura M.R., Aouada F.A., Mattoso L.H.C., Fraceto L.F. Evaluation of the genotoxicity of chitosan nanoparticles for use in food packaging films. J. Food Sci. 2010, 75:N89-N96.
16. Dhawan A., Sharma V. Toxicity assessment of nanomaterials: methods and challenges. Anal. Bioanal. Chem. 2010, 398:589-605.
17. Ding L., Stilwell J., Zhang T., Elboudwarej O., Jiang H., Selegue J.P., Cooke P.A., Gray J.W., Chen F.F. Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano Lett. 2005, 5:2448-2464.
18. Donaldson K., Stone V., Duffin R., Clouter A., Schins R., Borm P.J. The quartz hazard: effects of surface and matrix on inflammogenic activity. J. Environ. Pathol. Toxicol. Oncol. 2001, 1:109-118.
19. Donaldson K., Stone V., Tran C.L., Kreyling W., Borm P.J.A. Nanotoxicology. Occup. Environ. Med. 2004, 61:727-728.
20. Donaldson K., Aitken R., Tran L., Stone V., Duffin R., Forrest G., Alexander A. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol. Sci. 2006, 92:5-22.
21. Donaldson K., Borm P.J., Castranova V., Gulumian M. The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles. Part. Fibre Toxicol. 2009, 6:13-20.
22. Driscoll K.E., Carter J.M., Howard B.W., Hassenbein D.G., Pepelko W., Baggs R.B., Oberdoerster G. Pulmonary inflammatory, chemokine, and mutagenic responses in rats after subchronic inhalation of carbon black. Toxicol. Appl. Pharmacol. 1996, 136:372-380.
23. Drobne D. Nanotoxicology for safe and sustainable nanotechnology. Arch. Ind. Hyg. Toxicol. 2007, 58:471-478.
24. Elechiguerra J.L., Burt J.L., Morones J.R., Camacho-Bragado A., Gao X., Lara H.H., Yacaman M.J. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 2005, 3:6.
25. Englen M.D., Taylor S.M., Laegreid W.W., Silflow R.M., Leid R.W. The effects of different silicas on arachidonic acid metabolism in alveolar macrophages. Exp. Lung Res. 1990, 16:691-709.
26. Fabian E., Landsiedel R., Ma-Hock L., Wiench K., Wohlleben W., van Ravenzwaay B. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch. Toxicol. 2008, 82:151-157.
27. Feliu N., Fadeel B. Nanotoxicology: no small matter. Nanoscale 2010, 2:2514-2520.
28. Fernandez-Urrusuno R., Fattal E., Feger J., Couvreur P., Therond P. Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. Biomaterials 1997, 18:511-517.
29. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5:161-171.
30. Fiorito S., Serafino A., Andreola F., Bernier P. Effects of fullerenes and single-wall carbon nanotubes on murine and human macrophages. Carbon 2006, 44:1100-1105.
31. Flahaut E., Durrieu M., Remy-Zolghadri M., Bareille R., Baquey C. Investigation of the cytotoxicity of CCVD carbon nanotubes towards human umbilical vein endothelial cells. Carbon 2006, 44:1093-1099.
32. Foley S., Crowley C., Smaihi M., Bonfils C., Erlanger B.F., Seta P. Cellular localization of a water-soluble fullerene derivative. Biochem. Biophys. Res. Commun. 2002, 294:116-119.
33. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 1995, 64:97-112.
34. Garnett M.C., Kallinteri P. Nanomedicines and nanotoxicology: some physiological principles. Occup. Med. 2006, 56:307-311.
35. Geng Y., Dalhaimer P., Cai S., Tsai R., Tewari M., Minko T., Discher D.E. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2007, 2:249-255.
36. George S., Xia T., Rallo R., Zhao Y., Ji Z., Lin S., Wang X., Zhang H., France B., Schoenfeld D., Damoiseaux R., Liu R., Lin S., Bradley K.A., Cohen Y., Nel A.E. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano 2011, 5:1805-1817.
37. Gillissen A., Gessner C., Hammerschmidt S., Hoheisel G., Wirtz H. Health significance of inhaled particles. Dtsch. Med. Wochenschr. 2006, 131:639-644.
38. Gontier E., Ynsa M.-D., Bíró T., Hunyadi J., Kiss B., Gáspár K., Pinheiro T., Silva J.-N., Filipe P., Stachura J., Dabros W., Reinert T., Butz T., Moretto P., Surlève-Bazeille J.-E. Is there penetration of titania nanoparticles in sunscreens through skin? A comparative electron and ion microscopy study. Nanotoxicology 2008, 2:218-231.
39. Gonzalez L., Sanderson B.J.S., Kirsch-Volders M. Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials. Mutagenesis 2011, 26:185-191.
40. Goodman C.M., McCusker C.D., Yilmaz T., Rotello V. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug. Chem. 2004, 15:897-900.
41. Gopee N.V., Roberts D.W., Webb P., Cozart C.R., Siitonen P.H., Warbritton A.R., Yu W.W., Colvin V.L., Walker N.J., Howard P.C. Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol. Sci. 2007, 98:249-257.
42. Gopinath P., Gogoi S.K., Chattopadhyay A., Ghosh S.S. Implications of silver nanoparticle induced cell apoptosis for in vitro gene therapy. Nanotechnology 2008, 19:1-10.
43. Griffiths S.M., Singh N., Jenkins G.J.S., Williams P.M., Orbaek A.W., Barron A.R., Wright C.J., Doak S.H. Dextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyes. Anal. Chem. 2011, 83:3778-3785.
44. Guang J., Haifang W., Lei Y., Xiang W., Rongjuan P., Tao Y., Yuliang Z., Xinbiao G. Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ. Sci. Technol. 2005, 39:1378-1383.
45. Hagens W.I., Oomen A.G., de Jong W.H., Cassee F.R., Sips A.J. What do we (need to) know about the kinetic properties of nanoparticles in the body?. Regul. Toxicol. Pharmacol. 2007, 49:217-219.
46. Hamilton R.F., Wu N.N., Porter D., Buford M., Wolfarth M., Holian A. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part. Fibre Toxicol. 2009, 6:35-45.
47. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ. Health Perspect. 2006, 114:165-172.
48. Herzog E., Casey A., Lyng F.M., Chambers G., Byrne H.J., Davoren M. A new approach to the toxicity testing of carbon-based nanomaterials-the clonogenic assay. Toxicol. Lett. 2007, 174:49-60.
49. Hirsch L.R., Stafford R.J., Bankson J.A., Sershen S.R., Rivera B., Price R.E., Hazle J.D., Halas N.J., West J.L. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. 2003, 100:13549-13554.
50. Hoyt V.W., Mason E. Nanotechnology: emerging health issues. J. Chem. Health Saf. 2008, 15:10-15.
51. Huang X.L., Zhang B., Ren L., Ye S.F., Sun L.P., Zhang Q.Q., Tan M.C., Chow G.M. In vivo toxic studies and biodistribution of near infrared sensitive Au-Au(2)S nanoparticles as potential drug delivery carriers. J. Mater. Sci. Mater. Med. 2008, 19:2581-2588.
52. Huang Y.-W., C-h Wu., Aronstam R.S. Toxicity of transition metal oxide nanoparticles: recent insights from in vitro studies. Materials 2010, 3:4842-4859.
53. Hund-Rinke K., Simon M. Ecotoxic effect of photocatalytic active nanoparticles (TiO2) on algae and daphnids. Environ. Sci. Pollut. Res. 2006, 13:225-232.
54. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 2005, 19:975-983.
55. Ishihara Y., Kyono H., Kohyama N., Otaki N., Serita F., Toya T., Kagawa J. Acute biological effects of intratracheally instilled titanium dioxide whiskers compared with nonfibrous titanium dioxide and amosite in rats. Inhal. Toxicol. 1999, 11:131-149.
56. Jain J., Arora S., Rajwade J.M., Omray P., Khandelwal S., Paknikar K.M. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol. Pharm. 2009, 6:1388-1401.
57. Jiang W., Betty Y.S.K., James T.R., Warren C.W.C. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 2008, 3:145-150.
58. Jin X., Li M., Wang J., Marambia-Jones C., Peng F., Huang X., Damoiseaux R., Hoek E.M.V. High-throughput screening of silver nanoparticle stability and bacterial inactivation in aquatic media: influence of specific ions. Environ. Sci. Technol. 2010, 44:7321-7328.
59. Jong W.H.D., Hagens W.I., Krystek P., Burger M.C., Sips A.J.A.M., Geertsma R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912-1919.
60. Jornot L., Petersen H., Junod A.F. Hydrogen peroxide-induced DNA damage is independent of nuclear calcium but dependent on redox-active ions. Biochem. J. 1998, 335:85-94.
61. Journeay W.S., Suri S.S., Moralez J.G., Fenniri H., Singh B. Rosette nanotubes show low acute pulmonary toxicity in vivo. Int. J. Nanomedicine 2008, 3:373-383.
62. Kabanov A.V. Polymer genomics: an insight into pharmacology and toxicology of nanomedicines. Adv. Drug Deliv. Rev. 2006, 58:1597-1621.
63. Kahru A., Dubourguier H.-C. From ecotoxicology to nanoecotoxicology. Toxicology 2010, 269:105-119.
64. 3 nanoparticles: microwave absorption and cytotoxicity study. Nanomed. Nanotechnol. Biol. Med. 2006, 2:217-221.
65. Kam N.W.S., Jessop T.C., Wender P.A., Dai H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc. 2004, 126:6850-6851.
66. Kanj R.S., Kang J.L., Castranova V. Interaction between primary alveolar macrophages and primary alveolar type II cells under basal conditions and after lipopolysaccharide or quartz exposure. J. Toxicol. Environ. Health A 2006, 69:1097-1116.
67. Karlsson H.L. The comet assay in nanotoxicology research. Anal. Bioanal. Chem. 2010, 398:651-666.
68. Kim S., Lim Y.T., Soltesz E.G., De Grand A.M., Lee J., Nakayama A., Parker J.A., Mihaljevic T., Laurence R.G., Dor D.M., Cohn L.H., Bawendi M.G., Frangioni J.V. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 2004, 22:93-97.
69. Knaapen A.M., Borm P.J.A., Albrecht C., Schins R.P. Inhaled particles and lung cancer. Part A: Mechanisms. Int J Cancer 2004, 109:799-809.
70. Kostarelos K., Lacerda L., Pastorin G., Wu W., Kieckowski S., Luangsivilay J., Godefroy S., Pantarotto D., Briand J., Muller S., Prato M., Bianco A. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol. 2007, 2:108-113.
71. Kroll A., Dierker C., Rommel C., Hahn D., Wohlleben W., Schulze-Isfort C., Göbbert C., Voetz M., Hardinghaus F., Schnekenburger J. Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays. Part. Fibre Toxicol. 2011, 8:9-28.
72. Kunzmann A., Andersson B., Thurnherr Tina, Krug H., Scheynius A., Fadeel B. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim. Biophys. Acta 2011, 1810:361-373.
73. Lademann J., Weigmann H., Rickmeyer C., Barthelmes H., Schaefer H., Mueller G., Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol. Appl. Skin Physiol. 1999, 12:247-256.
74. Lam P.K., Chan E.S., Ho W.S., Liew C.T. In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes. Br. J. Biomed. Sci. 2004, 61:125-127.
75. Lam C.W., James J.T., McCluskey R., Arepalli S., Hunter R.L. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol. 2006, 36:189-217.
76. Landsiedel R., Ma-Hock L., Kroll A., Hahn D., Schnekenburger J., Wiench K., Wohlleben W. Testing metal-oxide nanomaterials for human safety. Adv. Mater. 2010, 22:2601-2627.
77. Lanone S., Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr. Mol. Med. 2006, 6:651-663.
78. Lee H.-Y., Choi Y.-J., Jung E.-J., Yin H.-Q., Kwon J.-T., Kim J.-E., Im H.-T., Cho M.-H., Kim J.-H., Kim H.-Y., Lee B.-H. Genomics-based screening of differentially expressed genes in the brains of mice exposed to silver nanoparticles via inhalation. J. Nanopart. Res. 2010, 12:1567-1578.
79. Lewinski N., Colvin V., Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4:26-49.
80. Li S.-D., Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm. 2008, 5:496-504.
81. Li N., Sioutas C., Cho A., Schmitz D., Misra C., Sempf J. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ. Health Perspect. 2003, 111:455-460.
82. Li M., Pokhrel S., Jin X., Madler L., Damoiseaux R., Hoek E.M.V. Stability, bioavailability, and bacterial toxicity of ZnO and iron-doped ZnO nanoparticles in aquatic media. Environ. Sci. Technol. 2011, 45:755-761.
83. Liang X.-J., Chen C., Zhao Y., Jia L., Wang P.C. Biopharmaceutics and therapeutic potential of engineered nanomaterials. Curr. Drug Metab. 2008, 9:697-709.
84. Lockman P.R., Koziara J.M., Mumper R.J., Allen D.D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J. Drug Target. 2004, 12:635-641.
85. Loo C., Lin A., Hirsch L., Lee M.H., Barton J., Halas N., West J., Drezek R. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol. Cancer Res. Treat. 2004, 3:33-40.
86. Luo J., Borgens R., Shi R. Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury. J. Neurochem. 2002, 83:471-480.
87. Lyon D., Fortner J., Sayes C., Colvin V., Hughes J. Bacterial cell association and antimicrobial activity of a C60 water suspension. Environ. Toxicol. Chem. 2005, 24:2757-2762.
88. Lyon D., Adams L., Joshua C., Falkner J., Alvarez P.J.J. Antibacterial activity of fullerene water suspensions: effects of preparation method and particle size. Environ. Sci. Technol. 2006, 40:4360-4366.
89. MacNee W., Donaldson K. Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD. Eur. Respir. J. 2003, 21:47s-51s.
90. Makarucha A.J., Todorova N., Yarovsky I. Nanomaterials in biological environment: a review of computer modelling studies. Eur. Biophys. J. 2011, 40:103-115.
91. Mates J.M., Sanchez-Jimenez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front. Biosci. 1999, 4:339-345.
92. Maynard A.D., Warheit D.B., Philbert M.A. The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol. Sci. 2011, 120(S1):S109-S129.
93. Medina C., Santos-Martinez M.J., Radomski A., Corrigan O.I., Radomski M.W. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 2007, 150:552-558.
94. Metz K.M., Mangham A.M., Bierman M.J., Jin S., Hamers R.J., Pedersen J. Engineered nanomaterial transformation under oxidative environmental conditions: development of an in vitro biomimetic assay. Environ. Sci. Technol. 2009, 43:1598-1604.
95. Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J. 2005, 19:311-330.
96. Monteiro-Riviere N., Inman A.O. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 2006, 44:1070-1078.
97. Nanotoxicology: Characterization, Dosing and Health Effects 2007, Informa healthcare USA Inc. N.A. Monteiro-Riviere, C.L. Tran (Eds.).
98. Monteiro-Riviere N.A., Nemanich R.J., Inman A.O., Wang Y.Y., Riviere J.E. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol. Lett. 2005, 155:377-384.
99. Monteiro-Riviere N.A., Inman A.O., Zhang L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 2009, 234:222-235.
100. Morones J.R., Elechiguerra J.L., Camacho A., Holt K., Kouri J.B., Ramirez J.T., Yacaman M.J. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
101. Muangman P., Chuntrasakul C., Silthram S., Suvanchote S., Benjathanung R., Kittidacha S., Rueksomtawin S. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds. J. Med. Assoc. Thai. 2006, 89:953-958.
102. Muller J., Huaux F., Moreau N., Misson P., Heilier J., Delos M., Arras M., Fonseca A., Nagy J., Lison D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 2005, 207:221-231.
103. Myllynen P.K., Loughran M.J., Howard C.V., Sormunen R., Walsh A.A., Vahakangas K.H. Kinetics of gold nanoparticles in the human placenta. Reprod. Toxicol. 2008, 26:130-137.
104. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
105. Niazi J.H., Gu M.B. Toxicity of metallic nanoparticles inmicroorganisms - a review. Atmospheric and Biological Environmental Monitoring 2009, 193-206. Springer Science+Business Media B.V. Y.J. Kim (Ed.).
106. 3H dendrimer nanoparticle organ/tumor distribution. Pharm. Res. 2004, 21:476-483.
107. Niidome T., Yamagata M., Okamoto Y., Akiyama Y., Takahashi H., Kawano T., Katayama Y., Niidome Y. PEG-modified gold nanorods with a stealth character for in vivo applications. J. Control. Release 2006, 114:343-347.
108. Nikula K.J., Snipes M.B., Barr E.B., Griffith W.C., Henderson R.F., Mauderly J.L. Comparative pulmonary toxicities and carcinogenicities of chronically inhaled diesel exhaust and carbon black in F344 rats. Fundam. Appl. Toxicol. 1995, 25:80-94.
109. North M., Vulpe C.D. Functional toxicogenomics: mechanism-centered toxicology. Int. J. Mol. Sci. 2010, 11:4796-4813.
110. Nurkiewicz T.R., Porter D.W., Barger M., Millecchia L., Rao K.M., Marvar P.J., Hubbs A.F., Castranova V., Boegehold M.A. Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ. Health Perspect. 2006, 114:412-419.
111. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Lunts A., Kreyling W., Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J. Toxicol. Environ. Health 2002, 65:1531-1543.
112. Oberdorster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2005, 2:8-43.
113. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
114. Oldfors A., Fardeau M. The permeability of the basal lamina at the neuromuscular junction. An ultrastructural study of rat skeletal muscle using particulate tracers. Neuropathol. Appl. Neurobiol. 1983, 9:419-432.
115. Osaki F., Kanamori T., Sando S., Sera T., Aoyama Y. A quantum dot conjugated sugar ball and Its cellular uptake. On the size effects of endocytosis in the subviral region. J. Am. Chem. Soc. 2004, 126:6520-6521.
116. Ovrevik J., Myran T., Refsnes M., Lag M., Becher R., Hetland R.B., Schwarze P.E. Mineral particles of varying composition induce differential chemokine release from epithelial lung cells: importance of physico-chemical characteristics. Ann. Occup. Hyg. 2005, 49:219-231.
117. Paddle-Ledinek J.E., Nasa Z., Cleland H.J. Effect of different wound dressings on cell viability and proliferation. Plast. Reconstr. Surg. 2006, 117:110S-118S.
118. Pal S., Tak Y.K., Song J.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol. 2007, 73:1712-1720.
119. Pantarotto D., Briand J., Prato M., Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. 2004, 1:16-17.
120. Park K.H., Chhowalla M., Iqbal Z., Sesti F. Single-walled carbon nanotubes are a new class of ion channel blockers. J. Biol. Chem. 2003, 278:50212-50216.
121. Parks C.G., Conrad K., Cooper G.S. Occupational exposure to crystalline silica and autoimmune disease. Environ. Health Perspect. 1999, 5 (Suppl:793-802.
122. Ponti J., Sabbioni E., Munaro B., Broggi F., Marmorato P., Franchini F., Colognato R., Rossi F. Genotoxicity and morphological transformation induced by cobalt nanoparticles and cobalt chloride: an in vitro study in Balb/3T3 mouse fibroblasts. Mutagenesis 2009, 24:439-445.
123. Pulskamp K., Diabate S., Krug H.F. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol. Lett. 2007, 168:58-74.
124. Qin X.Y., Kim J.G., Lee J.S. Synthesis and magnetic properties of nanostructured γ-Ni-Fe alloys. Nanostruct. Mater. 1999, 11:259-270.
125. Radomski A., Jurasz P., Alonso-Escolano D., Drews M., Morandi M., Malinski T., Radomski M.W. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol. 2005, 146:882-893.
126. Roberts A.P., Mount A.S., Seda B., Souther J., Qiao R., Lin S., Ke P.C., Rao A.M., Klaine S.J. In vivo biomodification of lipid-coated carbon nanotubes by Daphnia magna. Environ. Sci. Technol. 2007, 41:3025-3029.
127. Rouse J.G., Yang J., Ryman-Rasmussen J.P., Barron A.R., Monteiro-Riviere N.A. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett. 2007, 7:155-160.
128. Russell-Jones G.J. Oral vaccine delivery. J. Control. Release 2000, 65:49-54.
129. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol. Sci. 2006, 91:159-165.
130. Sadik O.A., Zhou A.L., Kikandi S., Du N., Wang Q., Varner K. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials. J. Environ. Monit. 2009, 11:1782-1800.
131. Sarkar S., Sharma C., Yog R., Periakaruppan A., Jejelowo O., Thomas R., Barrera E.V., Rice-Ficht A.C., Wilson B.L., Ramesh G.T. Analysis of stress responsive genes induced by single-walled carbon nanotubes in BJ foreskin cells. J. Nanosci. Nanotechnol. 2007, 7:584-592.
132. Savolainen K., Alenius H., Norppa H., Pylkkänen L., Tuomi T., Kasper G. Risk assessment of engineered nanomaterials and nanotechnologies-A review. Toxicology 2010, 269:92-104.
133. Sayes C., Ivanov I. Comparative study of predictive computational models for nanoparticle-induced cytotoxicity. Risk Anal. 2010, 10.1111/j.1539-6924.2010.01438.x.
134. Sayes C.M., Fortner J.D., Guo W., Lyon D., Boyd A., Ausman K., Tao Y., Sitharaman B., Wilson L., Hughes J., West J., Colvin V. The differential cytotoxicity of water soluble fullerenes. Nano Lett. 2004, 4:1881-1887.
135. 60 cytotoxicity is due to lipid peroxidation. Biomaterials 2005, 26:7587-7595.
136. Sayes C.M., Reed K.L., Subramoney S., Abrams L., Warheit D.B. Can in vitro assays substitute for in vivo studies in assessing the pulmonary hazards of fine and nanoscale materials?. J. Nanopart. Res. 2009, 11:421-431.
137. Schaeublin N.M., Braydich-Stolle L.K., Schrand A.M., Miller J.M., Hutchison J., Schlagera J.J., Hussain S.M. Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 2011, 3:410-420.
138. Schins R.P.F., Duffin R., Hohr D., Ad M.Knaapen A.M., Shi T., Weishaupt C., Stone V., Donaldson K., Borm P.J.A. Surface modification of quartz inhibits toxicity, particle uptake, and oxidative DNA damage in human lung epithelial cells. Chem. Res. Toxicol. 2002, 15:1166-1173.
139. Scown T.M., Goodhead R.M., Johnston B.D., Moger J., Baalousha M., Lead J.R., van Aerle R., Iguchi T., Tyler C.R. Assessment of cultured fish hepatocytes for studying cellular uptake and (eco)toxicity of nanoparticles. Environ. Chem. 2010, 7:36-49.
140. Selvan S.T., Tan T.T., Ying J.Y. Robust, non-cytotoxic, silica-coated cdse quantum dots with efficient photoluminescence. Adv. Mater. 2005, 17:1620-1625.
141. Selverstov O., Zabirnyk O., Zscharnack M., Bulavina L., Nowicki M., Heinrich J.M., Yezhelyev M., Emmrich F., O'Regan R., Bader A. Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation. Nano Lett. 2006, 6:2826-2632.
142. Shukla R.K., Sharma V., Pandey A.K., Singh S., Sultana S., Dhawan A. ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells. Toxicol. In Vitro 2011, 25:231-241.
143. Shvedova A.A., Castranova V., Kisin E.R., Schwegler-Berry D., Murray A.R., Gandelsman V.Z., Maynard A., Baron P. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J. Toxicol. Environ. Health A 2003, 66:1909-1926.
144. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., Tyurina Y.Y., Gorelik O., Arepalli S., Schwegler-Berry D., Hubbs A.F., Antonini J., Evans D.E., Ku B.K., Ramsey D., Maynard A., Kagan V.E., Castranova V., Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:698-708.
145. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., Tyurina Y.Y., Gorelik O., Arepalli S., Schwegler-Berry D., Hubbs A.F., Antonini J., Evans D.E., Ku B.K., Ramsey D., Maynard A., Kagan V.E., Castranova V., Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:698-708.
146. Shvedova A.A., Kagan V.E., Fadeel B. Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Ann. Rev. Pharmacol. Toxicol. 2010, 50:63-88.
147. Singh N., Manshian B., Jenkins G.J.S., Griffiths S.M., Williams P.M., Maffeis T.G.G., Wright C.J., Doak S.H. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009, 30:3891-3914.
148. Smith M.W., Thomas N.W., Jenkins P.G., Miller N.G., Cremaschi D., Porta C. Selective transport of microparticles across Peyer's patch follicle-associated M cells from mice and rats. Exp. Physiol. 1995, 80:735-743.
149. Smith C.J., Shaw B.J., Handy R.D. Toxicity of single walled carbon nanotubes to rainbow trout, (Oncorhynchus mykiss): respiratory toxicity, organ pathologies, and other physiological effects. Aquat. Toxicol. 2007, 82:94-109.
150. Sonavane G., Tomoda K., Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf. B Biointerfaces 2008, 66:274-280.
151. Soto K., Garza K.M., Murr L.E. Cytotoxic effects of aggregated nanomaterials. Acta Biomater. 2007, 3:351-358.
152. Stahl W., Junghans A., De Boer B., Driomina E.S., Brivida K., Sies H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett. 1998, 427:305-308.
153. Supp A.P., Neely A.N., Supp D.M., Warden G.D., Boyce S.T. Evaluation of cytotoxicity and antimicrobial activity of Acticoat burn dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice. J. Burn Care Rehabil. 2005, 26:238-246.
154. Takenaka S., Karg E., Roth C., Schulz H., Ziesenis A., Heinzmann U., Schramel P., Heyder J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 2001, 4:547-551.
155. Takhar P., Mahant S. In vitro methods for nanotoxicity assessment: advantages and applications. Arch. Appl. Sci. Res. 2011, 3:389-403.
156. Templeton R., Leeferguson P., Washburn K., Scrivens W., Thomaschandler G. Life-cycle effects of singlewalled carbon nanotubes (SWNTs) on an estuarine meiobenthic copepod. Environ. Sci. Technol. 2006, 40:7387-7393.
157. Tian F., Cui D., Schwarz H., Estrada G.G., Kobayashi H. Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol. In Vitro 2006, 20:1202-1212.
158. Tinkle S.S., Antonini J.M., Rich B.A., Roberts J.R., Salmen R., DePree K., Adkins E.J. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ. Health Perspect. 2003, 111:1202-1208.
159. Tran C.L., Buchanan R.T., Cullen R.T., Searl A., Jones A.D., Donaldson K. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhalation Toxicol. 2000, 12:1113-1126.
160. Trop M., Novak M., Rodl S., Hellbom B., Kroell W., Goessler W. Silver-coated dressing Acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J. Trauma 2006, 60:648-652.
161. Uo M., Tamura K., Sato Y., Yokoyama A., Watari F., Totsuka Y., Tohji K. The cytotoxicity of metal encapsulating carbon nanocapsules. Small 2005, 1:816-819.
162. Usenko C.Y., Harper S.L., Tanguay R.L. In vivo evaluation of carbon fullerene toxicity using embryonic zebrafish. Carbon 2007, 45:1891-1898.
163. Vallyathan V., Shi X. The role of oxygen free radicals in occupational and environmental lung diseases. Environ. Health Perspect. 1997, 105:165-177.
164. van der Merwe, Tawde S., Pickrell J.A., Erickson L.E. Nanocrystalline titanium dioxide and magnesium oxide in vitro dermal absorption in human skin. Cutaneous Ocul. Toxicol. 2009, 28:78-82.
165. Vasir J.K., Reddy M.K., Labhasetwar V.D. Nanosystems in drug targeting: opportunities and challenges. Curr. Nanosci. 2005, 1:47-64.
166. Wakefield G., Lipscomb S., Holland E., Knowland John The effects of manganese doping on UVA absorption and free radical generation of micronised titanium dioxide and its consequences for the photostability of UVA absorbing organic sunscreen components. Photochem. Photobiol. Sci. 2004, 3:648-652.
167. Wang B., Wang Z., Feng W., Wang M., Hu Z., Chai Z., Zhao Y. New methods for nanotoxicology: synchrotron radiation-based techniques. Anal. Bioanal. Chem. 2010, 398:667-676.
168. Warheit D.B. Inhaled amorphous silica particulates: what do we know about their toxicological profiles?. J. Environ. Pathol. Toxicol. Oncol. 2001, 1:133-141.
169. Warheit D.B., Sayes C.M., Reed K.L. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures?. Environ. Sci. Technol. 2009, 43:7939-7945.
170. Webster T.J., Siegel R.W., Bizios R. Osteoblast adhesion on nanophase ceramics. Biomaterials 1999, 20:1221-1227.
171. Webster T.J., Ergun C., Doremus R.H. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 2000, 21:1803-1810.
172. Wick P., Manser P., Limbach L.K., Dettlaff-Weglikowska U., Krumeich F., Roth S., Stark W.J., Bruinink A. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol. Lett. 2007, 168:121-131.
173. Witzmann F.A., Monteiro-Riviere N.A. Multi-walled carbon nanotube exposure alters protein expression in human keratinocytes. Nanomedicine 2006, 2:158-168.
174. Wright J.B., Lam K., Buret A.G., Olson M.E., Burrell R.E. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen. 2002, 10:141-151.
175. Xia T., Zhao Y., Sager T., George S., Pokhrel S., Li N., Schoenfeld D., Meng H., Lin S., Wang X., Wang M., Ji Z., Zink J.I., Meadler L., Castranova V., Lin Shuo, Nel A.E. Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano 2011, 5:1223-1235.
176. Yang Z., Liu Z.W., Allaker R.P., Reip P., Oxford J., Ahmad Z., Ren G. A review of nanoparticle functionality and toxicity on the central nervous system. J. R. Soc. Interface 2010, 7:S411-S422.
177. Yeates D.B., Mauderly J.L. Inhaled environmental/occupational irritants and allergens: mechanisms of cardiovascular and systemic responses. Introduction. Environ. Health Perspect. 2001, 4:479-481.
178. Yu T., Malugin A., Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 2011, Published online 10.1021/nn2013904.
179. Zhang L.W., Zeng L., Barron A.R., Monteiro-Riviere N.A. Biological interactions of functionalized single-wall carbon nanotubes in human epidermal keratinocytes. Int. J. Toxicol. 2007, 26:103-113.
180. ZhiYong Z., YuLiang Z., ZhiFang C. Applications of radiotracer techniques for the pharmacology and toxicology studies of nanomaterials. Chin. Sci. Bull. 2009, 54:173-182.
181. Zhu S.Q., Oberdorster E., Haasch M.L. Toxicity of an engineered nanoparticle (fullerene, C60) in two aquatic species, Daphnia and fathead minnow. Mar. Environ. Res. 2006, 62(Supplement 1):S5-S9.
182. Zhu X., Zhu L., Li Y., Duan Z., Chen W., Alvarez P.J.J. Developmental toxicity in zebrafish embryos after exposure to manufactured nanomaterials: buckminsterfullerene aggregates (nC60) and fullerol. Environ. Toxicol. Chem. 2007, 26:976-979.
183. Zhu X., Zhu L., Li Y., Qi R., Duan Z., Lang Y.P. Comparative toxicity of several metal oxide nano-particle aqueous suspensions to zebrafish (Danio rerio) early developmental stage. J. Environ. Sci. Health A 2008, 43:278-284.
184. Zhu X., Zhu L., Chen Y., Tian S. Acute toxicities of six manufactured nanomaterial suspensions to Daphnia magna. J. Nanopart. Res. 2009, 11:67-75.
185. Zwart L.L.D., Haenen H.E., Versantvoort C.H., Wolterink G., van Engelen J.G., Sips A.J. Role of biokinetics in risk assessment of drugs and chemicals in children. Regul. Toxicol. Pharmacol. 2004, 39:282-309.